- Report
- July 2025
- 364 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 283 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 285 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 368 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 364 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 93 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 529 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- July 2025
- 216 Pages
Global
From €5154EUR$5,850USD£4,471GBP
- Report
- August 2024
- 170 Pages
Global
From €3965EUR$4,500USD£3,439GBP
- Report
- June 2025
- 185 Pages
Global
From €3965EUR$4,500USD£3,439GBP
- Report
- May 2025
- 139 Pages
Global
From €2642EUR$2,999USD£2,292GBP
- Report
- April 2025
- 146 Pages
Global
From €2642EUR$2,999USD£2,292GBP
- Report
- January 2025
- 125 Pages
Global
From €2642EUR$2,999USD£2,292GBP
- Report
- September 2024
- 142 Pages
Global
From €2642EUR$2,999USD£2,292GBP
- Report
- August 2024
- 141 Pages
Global
From €2642EUR$2,999USD£2,292GBP
- Report
- June 2025
- 185 Pages
Global
From €3370EUR$3,825USD£2,923GBP
€3965EUR$4,500USD£3,439GBP
- Report
- December 2024
- 200 Pages
Global
From €3304EUR$3,750USD£2,866GBP
- Report
- June 2025
- 180 Pages
Global
From €3370EUR$3,825USD£2,923GBP
€3965EUR$4,500USD£3,439GBP
- Report
- June 2025
- 185 Pages
Global
From €3370EUR$3,825USD£2,923GBP
€3965EUR$4,500USD£3,439GBP
- Report
- June 2025
- 183 Pages
Global
From €3370EUR$3,825USD£2,923GBP
€3965EUR$4,500USD£3,439GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more